Other languages Pacific Biosciences of California, Inc.

Equities

PACB

US69404D1081

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
1.47 ^USD	+6.52%		-5.16%	-85.02%

Apr. 22	JPMorgan Downgrades Pacific Biosciences of California to Neutral From Overweight	MT
Apr. 18	Scotiabank Adjusts Pacific Biosciences of California's Price Target to $8 From $15, Maintains Sector Outperform Rating	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Pacific Biosciences of California Q1 Revenue Expected to Be Flat Year Over Year; Guidance Lowered; Shares Sink	Apr. 16
Pacific Biosciences of California, Inc. Provides Revenue Guidance for the Second Quarter and Full Year 2024	Apr. 16
Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes	Mar. 27
PacBio Announces PureTarget Repeat Expansion Panel, Expanding Its Portfolio of End-To-End Clinical Research Solutions	Mar. 12
Pacific Biosciences of California Q4 Non-GAAP Loss Narrows, Revenue Rises; Shares Drop After Hours	Feb. 15
Pacific Biosciences of California, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 15
Pacific Biosciences of California, Inc Announces HiFi Prep Kit 96 and HiFi Plex Prep Kit 96 for Long-Read Sequencing Applications at Scale	Feb. 05
PacBio Announces New Nanobind Pandna Kit Enabling Hifi Optimized Dna Extraction Solutions	Jan. 15
Pacific Biosciences Posts Higher Preliminary Q4, Full-Year 2023 Revenue	Jan. 08
Pacific Biosciences of California, Inc. Announces Resignation of David Botstein from the Board	Dec. 11
Pacific Biosciences of California Shares Rise After UBS Upgrade	Nov. 17
PacBio Announces HiFi Solves, a Global Consortium of Clinical Genomics Research Leaders	Nov. 02
Pacific Biosciences of California Teams Up With Geneyx, Golden Helix in Disease Research	Nov. 01
PacBio Enables Rare and Inherited Disease Research by Adding Tertiary Analysis Partners to PacBio Compatible	Nov. 01
Pacific Biosciences of California Q3 Loss Narrows, Revenue Gains	23-10-30
Pacific Biosciences of California, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-30
Pacific Biosciences of California, Inc. Appoints David Meline to Audit Committee	23-10-27
Pacific Biosciences of California, Inc. Appoints David Meline to its Board of Directors	23-10-16
Pacbio Announces Complete Computational Workflow for Human Whole Genome Sequencing Data Analysis	23-10-11
Children's Mercy Kansas City First to Use 5-Base HiFi Sequencing from PacBio	23-10-06

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Pacific Biosciences of California, Inc.

Equities

PACB

US69404D1081

Other languages

Filters